M N Rossor

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi Pick's disease: a clinical overview
    M N Rossor
    Dementia Research Group, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Neurology 56:S3-5. 2001
  2. ncbi Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation
    J C Janssen
    Dementia Research Group, Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, England
    Arch Neurol 58:953-8. 2001
  3. ncbi Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy
    A D Waldman
    Dementia Research Group, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, WC1 3BG, UK
    Neuroradiology 48:428-33. 2006
  4. ncbi Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease
    D Chan
    Department of Clinical Neurology, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, UK
    Ann Neurol 49:433-42. 2001
  5. ncbi Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia
    A J Green
    Department of Neuroimmunology, National Hospital for Neurology and Neurosurgery, London, UK
    Neurosci Lett 235:5-8. 1997
  6. ncbi Knight's move thinking? Mild cognitive impairment in a chess player
    H A Archer
    The Dementia Research Centre, The National Hospital for Neurology and Neurosurgery, London, UK
    Neurocase 11:26-31. 2005
  7. ncbi A decade of pre-diagnostic assessment in a case of familial Alzheimer's disease: tracking progression from asymptomatic to MCI and dementia
    A K Godbolt
    Dementia Research Group, Institute of Neurology, Queen Square, London, UK
    Neurocase 11:56-64. 2005
  8. ncbi Neuropsychological correlates of whole brain atrophy in Alzheimer's disease
    J M Schott
    Dementia Research Centre National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Neuropsychologia 46:1732-7. 2008
  9. ncbi Brain biopsy in dementia
    J D Warren
    Dementia Research Centre, Institute of Neurology, London, UK
    Brain 128:2016-25. 2005
  10. ncbi A second family with familial AD and the V717L APP mutation has a later age at onset
    A K Godbolt
    Dementia Research Centre, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Neurology 66:611-2. 2006

Detail Information

Publications70

  1. ncbi Pick's disease: a clinical overview
    M N Rossor
    Dementia Research Group, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Neurology 56:S3-5. 2001
    ....
  2. ncbi Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation
    J C Janssen
    Dementia Research Group, Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, England
    Arch Neurol 58:953-8. 2001
    ..CONCLUSIONS: The PSEN1 L153V mutation lies in the main mutation cluster of PSEN1 in the second transmembrane domain. It causes early-onset FAD with clinical features similar to those of other reported FAD pedigrees...
  3. ncbi Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy
    A D Waldman
    Dementia Research Group, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, WC1 3BG, UK
    Neuroradiology 48:428-33. 2006
    ....
  4. ncbi Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease
    D Chan
    Department of Clinical Neurology, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, UK
    Ann Neurol 49:433-42. 2001
    ..In addition, the pattern of atrophy in semantic dementia suggests that semantic memory is subserved by anterior temporal lobe structures, within which the middle and inferior temporal gyri may play a key role...
  5. ncbi Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia
    A J Green
    Department of Neuroimmunology, National Hospital for Neurology and Neurosurgery, London, UK
    Neurosci Lett 235:5-8. 1997
    ..001). There was no correlation between age at disease onset, disease severity or length of illness. The increased concentration of CSF S100beta seen in frontotemporal dementia may reflect the marked astrocytosis seen in this condition...
  6. ncbi Knight's move thinking? Mild cognitive impairment in a chess player
    H A Archer
    The Dementia Research Centre, The National Hospital for Neurology and Neurosurgery, London, UK
    Neurocase 11:26-31. 2005
    ....
  7. ncbi A decade of pre-diagnostic assessment in a case of familial Alzheimer's disease: tracking progression from asymptomatic to MCI and dementia
    A K Godbolt
    Dementia Research Group, Institute of Neurology, Queen Square, London, UK
    Neurocase 11:56-64. 2005
    ..Longitudinal MRI, neuropsychological and clinical data are presented over the decade preceding this man's diagnosis, through the asymptomatic and prodromal preludes to his presentation with MCI and on to eventual conversion to AD...
  8. ncbi Neuropsychological correlates of whole brain atrophy in Alzheimer's disease
    J M Schott
    Dementia Research Centre National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Neuropsychologia 46:1732-7. 2008
    ..This methodology whereby data from patients falling to floor on a given test may be included and accounted for, rather than discarded, may find broader application in clinical studies incorporating neuropsychometric outcomes...
  9. ncbi Brain biopsy in dementia
    J D Warren
    Dementia Research Centre, Institute of Neurology, London, UK
    Brain 128:2016-25. 2005
    ....
  10. ncbi A second family with familial AD and the V717L APP mutation has a later age at onset
    A K Godbolt
    Dementia Research Centre, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Neurology 66:611-2. 2006
  11. ncbi MRS shows abnormalities before symptoms in familial Alzheimer disease
    A K Godbolt
    Dementia Research Centre, Institute of Neurology, University College of London, London, UK
    Neurology 66:718-22. 2006
    ..CONCLUSIONS: Metabolic changes are detectable in presymptomatic mutation carriers years before expected onset of Alzheimer disease. Their magnitude is related to proximity of expected age at onset...
  12. ncbi The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease
    R J Cordery
    Dementia Research Group, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    J Neurol Neurosurg Psychiatry 76:330-6. 2005
    ..The results also suggest that nominal function may be preserved in some cases with inherited prion disease...
  13. ncbi A presenilin 1 R278I mutation presenting with language impairment
    A K Godbolt
    Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, London, UK
    Neurology 63:1702-4. 2004
    ..Screening for PSEN1 mutations may be appropriate in cases of familial dementia even where the clinical phenotype is not typical of AD...
  14. ncbi Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration
    J C Janssen
    Dementia Research Group, Institute of Neurology, Queen Square, London WC1N 3BG, UK
    J Neurol Neurosurg Psychiatry 76:162-8. 2005
    ..Fluid registered MRI may be a useful technique in assessing patterns of focal atrophy in vivo and demonstrating the progression of degenerative diseases...
  15. ncbi Rates of global and regional cerebral atrophy in AD and frontotemporal dementia
    D Chan
    Dementia Research Group, Department of Clinical Neurology, Institute of Neurology, London, UK
    Neurology 57:1756-63. 2001
    ..Increased rates of whole-brain atrophy did not discriminate AD from FTD, but analysis of regional atrophy rates revealed marked differences between patient groups...
  16. ncbi Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images
    N C Fox
    Dementia Research Group, Department of Clinical Neurology, Institute of Neurology, University College London, London, UK
    Lancet 358:201-5. 2001
    ..We used an imaging technique known as voxel-compression mapping to localise progressive atrophy in patients with preclinical Alzheimer's disease...
  17. ncbi Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease
    H A Archer
    Dementia Research Centre, UCL Institute of Neurology, London, UK
    Int J Geriatr Psychiatry 25:1119-26. 2010
    ..To determine rates of cerebral atrophy in individuals with symptoms of memory loss but no objective cognitive impairment (SNCI) and their association with future cognitive decline...
  18. ncbi A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer's disease
    W D Knight
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    Eur J Neurol 14:829-31. 2007
    ..They are, however, consistent with the reported clinical phenotype in the majority of PSEN1 exon 6 mutations so far reported...
  19. ncbi Acceleration of cortical thinning in familial Alzheimer's disease
    W D Knight
    Dementia Research Centre, UCL Institute of Neurology, University College London, Queen Square, London, WC1N 3BG, UK
    Neurobiol Aging 32:1765-73. 2011
    ..We used automated cortical thickness (CTh) measurement to compare the grey matter of such a group with cognitively normal controls...
  20. ncbi Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study
    N C Fox
    The National Hospital for Neurology and Neurosurgery, London, UK
    Brain 121:1631-9. 1998
    ..This may have implications for the detection and treatment of Alzheimer's disease at an early stage...
  21. ncbi Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
    A J Green
    Department of Neuroimmunology, National Hospital for Neurology and Neurosurgery, London, UK
    Neurosci Lett 259:133-5. 1999
    ..In neither disease did CSF tau correlate with disease severity as assessed by the Mini Mental State Examination score (MMSE). This study shows that CSF tau is significantly raised in patients with frontotemporal dementia...
  22. ncbi Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration
    J D Rohrer
    Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    Neurology 72:1562-9. 2009
    ..Two subtypes commonly present with a language disorder: semantic dementia (SemD) and progressive nonfluent aphasia (PNFA)...
  23. ncbi EEG abnormalities in frontotemporal lobar degeneration
    D Chan
    Dementia Research Group, National Hospital for Neurology, London, UK
    Neurology 62:1628-30. 2004
    ..There was no significant difference in the severity of EEG abnormality between the FTLD and AD patient groups. These data suggest a need for reappraisal of the role of the EEG in the diagnostic differentiation of FTLD from AD...
  24. ncbi Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes
    E K Warrington
    Department of Clinical Neurology, Institute of Neurology, London, UK
    J Neurol 248:45-50. 2001
    ..This study provides further evidence of the heterogeneity of the disease process...
  25. ncbi Dementia with Lewy bodies studied with positron emission tomography
    R J Cordery
    Dementia Research Group, Department of Clinical Neurology, Institute of Neurology and Division of Neurosciences, Imperial College School of Medicine, London, UK
    Arch Neurol 58:505-8. 2001
    ..We suggest that although this finding may favor a diagnosis of dementia with Lewy bodies, it is not necessary for diagnosis...
  26. ncbi Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials
    J M Schott
    Dementia Research Centre, Institute of Neurology, University College London, Queen Square, Box 16, WC1N 3BG, London, UK
    J Neurol 253:1147-53. 2006
    ..We conclude that sample sizes required in short interval therapeutic trials using cerebral atrophy as an outcome measure may be reduced if multiple serial MRI is performed...
  27. ncbi Early onset familial Alzheimer's disease: Mutation frequency in 31 families
    J C Janssen
    Dementia Research Group, Department of Clinical Neurology, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, UK
    Neurology 60:235-9. 2003
    ..There may be a further genetic factor involved in the etiology of autosomal dominant early onset AD...
  28. ncbi The neuro-behavioural syndrome of brainstem disease
    R Omar
    Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, UK
    Neurocase 13:452-65. 2007
    ..We argue that cognitive and behavioural features in patients with brainstem lesions reflect remote effects of brainstem structures on frontal lobe and limbic regions, as a consequence of disruption to ascending neurotransmitter pathways...
  29. ncbi Young onset dementia
    E L Sampson
    Dementia Research Group, Institute of Neurology, University College London, London, UK
    Postgrad Med J 80:125-39. 2004
    ..This review presents an approach to the diagnosis, investigation, and management of patients with young onset dementia, with particular reference to common and treatable causes...
  30. ncbi Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements
    B H Ridha
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    AJNR Am J Neuroradiol 28:965-70. 2007
    ..This study assessed the value of measuring MTR in addition to volumetric MR in differentiating patients with AD from control subjects...
  31. ncbi The heritability and genetics of frontotemporal lobar degeneration
    J D Rohrer
    Dementia Research Centre, Institute of Neurology, Queen Square, London WC1N 3BG, UK
    Neurology 73:1451-6. 2009
    ..Frontotemporal lobar degeneration (FTLD) is a genetically and pathologically heterogeneous neurodegenerative disorder...
  32. ncbi Clinical and neuroimaging features of familial Alzheimer's disease
    M N Rossor
    Dementia Research Group, National Hospital for Neurology and Neurosurgery, London, United Kingdom
    Ann N Y Acad Sci 777:49-56. 1996
    ..Scanning of asymptomatic at-risk individuals reveals a similar, but quantitatively less severe, pattern of hypometabolism...
  33. ncbi Differential diagnosis of frontotemporal dementia: Pick's disease
    M N Rossor
    Dementia Research Group, Institute of Neurology, London, UK
    Dement Geriatr Cogn Disord 10:43-5. 1999
    ..An EU-funded consortium has examined a retrospective series of neuropathologically confirmed Pick's disease cases to explore potential clinical diagnostic features. From these, draft clinical criteria have been developed...
  34. ncbi Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine
    B H Ridha
    Dementia Research Centre, National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK
    Neurology 65:481-2. 2005
    ..Significant resolution occurred once treatment was discontinued. Caution is required when prescribing memantine to patients with possible DLB...
  35. ncbi Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
    N C Fox
    Dementia Research Centre, Institute of Neurology, London, UK
    Neurology 64:1563-72. 2005
    ..Reported are MRI findings of a Phase IIa immunotherapy trial in AD prematurely terminated owing to meningoencephalitis in a subset of patients...
  36. ncbi Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease
    A Petzold
    Institute of Neurology, Department of Neuroinflammation, Queen Square, London WC1N 3BG, UK
    Neurosci Lett 336:167-70. 2003
    ..53, P<0.001). No such correlation was found for FTLD patients. This study supports the concept that S100B is of pathological relevance for degeneration of the central nervous system in AD...
  37. ncbi An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels
    A Petzold
    Department of Neuroimmunology, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
    Exp Neurol 223:432-8. 2010
    ..This cutoff level was confirmed in a prospective audit (n=100). As demand for CSF tau levels will increase globally, the accuracy of local CSF hTau cutoff levels can be compared against this benchmark...
  38. ncbi The prevalence and causes of dementia in people under the age of 65 years
    R J Harvey
    Imperial College London and the Institute of Neurology UCL, London, UK
    J Neurol Neurosurg Psychiatry 74:1206-9. 2003
    ..To determine the prevalence of dementia in people under the age of 65 in a large catchment area, and use these figures to estimate the number of younger people affected by dementia in the UK...
  39. ncbi The prevalence of oligoclonal bands in the CSF of patients with primary neurodegenerative dementia
    J C Janssen
    Dementia Research Group, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, WC1N 3BG, London, UK
    J Neurol 251:184-8. 2004
    ..CONCLUSION: A central immune response can occur in primary neurodegenerative dementias, albeit uncommonly...
  40. ncbi Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration
    Y A L Pijnenburg
    Department of Clinical Neurology, Institute of Neurology, London, UK
    Int J Geriatr Psychiatry 18:67-72. 2003
    ..We suggest that neuroleptics should be used cautiously in FTLD and treatment should be started at low doses avoiding depot preparations until further prospective studies have been performed...
  41. ncbi Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy
    D C Paviour
    The Sara Koe PSP Research Centre, Institute of Neurology UCL, London, UK
    J Neurol Neurosurg Psychiatry 75:1772-5. 2004
    ..MRI features described previously in PSP correspond to regions of pathological involvement demonstrated in separate studies, but serial MRI with pathological follow up has not been undertaken...
  42. ncbi A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia
    A Petzold
    Department of Neuroimmunology, Institute of Neurology, UCL, London, UK
    Neurodegener Dis 4:185-94. 2007
    ..Loss of cortical neurons is a key pathological feature in neurodegenerative dementias. Cerebrospinal fluid (CSF) neurofilaments (Nf) are a biomarker for neuronal death and axonal loss...
  43. ncbi Amnesia, cerebral atrophy, and autoimmunity
    J M Schott
    Dementia Research Group, Institute of Neurology, University College WC1N 3BG, London, UK
    Lancet 361:1266. 2003
  44. ncbi Genetics of the dementias
    J M Schott
    Dementia Research Group, National Hospital for Neurology and Neurosurgery, Institute of Neurology, Queen Square, London, UK
    J Neurol Neurosurg Psychiatry 73:II27-31. 2002
  45. ncbi Scintigraphy with 123I-serum amyloid P component in Alzheimer disease
    L B Lovat
    Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK
    Alzheimer Dis Assoc Disord 12:208-10. 1998
    ..Also, although plasma-derived SAP is always present in the cerebral and cerebrovascular amyloid lesions of AD, there was insufficient accumulation of injected labeled SAP to be detected by the present routine methodology...
  46. ncbi Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation
    J C Janssen
    Dementia Research Group, Institute of Neurology, London, UK
    Neurology 58:1161-8. 2002
    ..To describe the clinical features of nine British families with neuropathologically verified frontotemporal dementia (FTD) due to the intronic tau exon 10(+16) mutation...
  47. ncbi Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease
    R J Cordery
    Dementia Research Group, Institute of Neurology, University College London, London, UK
    Eur Radiol 16:1692-8. 2006
    ..The magnitude of metabolite abnormalities in the thalami in moderately advanced vCJD suggests a potential role in earlier diagnosis. Short TE protocols allow the measurement of MI, which adds discriminant power to the MRS examination...
  48. ncbi Clinical-anatomical correlation in a selective phonemic speech production impairment
    A J Larner
    Dementia Research Group, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    J Neurol Sci 219:23-9. 2004
    ....
  49. ncbi Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment
    R J Cordery
    Dementia Research Group, Institute of Neurology, University College London, London WC1, UK
    J Neurol Neurosurg Psychiatry 74:1412-6. 2003
    ..CONCLUSIONS: These findings suggest that, although not the presenting feature, mild cognitive decline may be evident in the early stages of CJD associated with human cadaveric growth hormone treatment...
  50. ncbi The grasp and other primitive reflexes
    J M Schott
    Dementia Research Group, National Hospital for Neurology and Neurosurgery, Institute of Neurology, University College, London, UK
    J Neurol Neurosurg Psychiatry 74:558-60. 2003
    ..In this review we discuss some historical aspects surrounding these reflexes, how they might be elicited and interpreted, and their potential clinical utility in modern neurological practice...
  51. ncbi The genetic and pathological classification of familial frontotemporal dementia
    H R Morris
    Neurogenetics Section, Institute of Neurology, University College London, England
    Arch Neurol 58:1813-6. 2001
    ..Furthermore, these data suggest that there are at least 2 additional genes to be identified among families with autosomal dominant FTD...
  52. ncbi Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging
    J Barnes
    Dementia Research Centre, UCL, Institute of Neurology, London, United Kingdom
    Neurobiol Aging 29:1199-203. 2008
    ..This has implications where shorter inter-scan intervals may be advantageous, such as rapid diagnosis, and tracking of disease progression including in a clinical trial...
  53. ncbi Neuronal loss in familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions
    N J Cairns
    Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia 19104, USA
    Exp Neurol 181:319-26. 2003
    ..This study shows that familial FTDU has profound focal neuronal loss in multiple association areas that relate to the clinical symptoms characteristic of the disease...
  54. ncbi Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition
    K Ishii
    Department of Molecular Biology, Tokyo Institute of Psychiatry, Tokyo, Japan
    Neurobiol Aging 22:367-76. 2001
    ..Our results suggest that PS-1 mutations affect cerebral accumulation of Abeta burden in a different fashion from APP717 mutations in their familial AD brains...
  55. ncbi Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene
    R J Harvey
    Dementia Research Group, The National Hospital for Neurology and Neurosurgery and Imperial College School of Medicine at St Mary s, London, UK
    J Neurol Neurosurg Psychiatry 64:44-9. 1998
    ....
  56. ncbi Do symptoms of memory impairment correspond to cognitive impairment: a cross sectional study of a clinical cohort
    H A Archer
    Institute of Neurology, Dementia Research Centre, London, WC1N 3BG
    Int J Geriatr Psychiatry 21:1206-12. 2006
    ..The SNCI group may represent a heterogeneous group with some individuals in the early stages of AD whilst others' memory complaints are more likely linked to anxiety or personality traits...
  57. ncbi Frontotemporal lobar degeneration and ubiquitin immunohistochemistry
    K A Josephs
    Department of Neurology, Mayo Clinic, Rochester, USA
    Neuropathol Appl Neurobiol 30:369-73. 2004
    ..Therefore in our brain bank series of frontotemporal degeneration, most cases were non-tauopathies with FTLD-U accounting for 62% of all the diagnoses...
  58. ncbi The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
    H H Klünemann
    Department of Psychiatry, University of Regensburg School of Medicine, Germany
    Neurology 64:1502-7. 2005
    ..The clinical course of PLOSL has not been characterized in a series of patients with TREM2 mutations...
  59. ncbi Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months
    J M Schott
    Dementia Research Centre, Institute of Neurology, University College London, UK
    Neurology 65:119-24. 2005
    ..This potential benefit must be balanced against the possibility that ventricular volumes may be more likely to be affected by factors other than neurodegeneration...
  60. ncbi A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies
    M G Spillantini
    Brain Repair Centre, University of Cambridge, UK
    Ann Neurol 48:939-43. 2000
    ..By exon trapping, the mutation produced an increase in the splicing in of exon 10, indicating that it probably causes disease through an overproduction of four-repeat tau...
  61. ncbi Transient ischaemic attacks are associated with increased rates of global cerebral atrophy
    R J L Walters
    Department of Clinical Neurology, St Mary's Hospital, London W2 1NY, UK
    J Neurol Neurosurg Psychiatry 74:213-6. 2003
    ..Future studies should assess whether this atrophy inevitably leads to cognitive decline, and whether aggressive treatment of risk factors for cerebrovascular disease (particularly hypertension) after a TIA can influence outcome...
  62. ncbi Sequence analysis of tau in familial and sporadic progressive supranuclear palsy
    H R Morris
    University Department of Clinical Neurology, Institute of Neurology, Queen Square, London WC1NBG, UK
    J Neurol Neurosurg Psychiatry 72:388-90. 2002
    ..This suggests that usually FTDP-17 and PSP, including the rare familial form of PSP, are likely to be separate conditions and that usually PSP and typical PSP-like syndromes are not due to mutations in tau...
  63. ncbi Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities
    P McMonagle
    St. Vincent's University Hospital, Dublin, Ireland
    Neurology 59:1108-10. 2002
    ..Another affected sibling also had MRI white matter abnormalities. The MRI findings may reflect an ischemic leukoencephalopathy due to amyloid angiopathy affecting meningocortical vessels...
  64. ncbi Pathogenic presenilin 1 mutations (P436S & I143F) in early-onset Alzheimer's disease in the UK. Mutations in brief no. 223. Online
    M S Palmer
    Molecular Genetics, Biomedical Sciences Division, Imperial College School of Medicine, London, UK
    Hum Mutat 13:256. 1999
    ..I143F shows incomplete penetration within the affected family. P436S is the most carboxy-terminal presenilin 1 mutation reported to date...
  65. ncbi Analysis of tau haplotypes in Pick's disease
    H R Morris
    Neurogenetics, Institute of Neurology, Reta Lila Weston Institute of Neurological Research, University College London, UK
    Neurology 59:443-5. 2002
    ..There was no difference between the tau H2 haplotype or H2H2 genotype frequency in PiD cases and control subjects. No tau mutations were identified in pathologically typical cases of PiD, with antibody 12-E8-negative Pick bodies...
  66. ncbi The cultural context of visual hallucinations
    W D Knight
    Dementia Research Centre, Institute of Neurology, 8 11 Queen Square, London WC1N 3BG, UK
    Postgrad Med J 84:103-5. 2008
    ..We discuss this issue using three illustrative cases...
  67. ncbi Neuropathologic variation in frontotemporal dementia due to the intronic tau 10(+16) mutation
    P L Lantos
    Department of Neuropathology, Institute of Psychiatry, King s College London, UK
    Neurology 58:1169-75. 2002
    ..An increasing number of recently described tau mutations show considerable clinical heterogeneity. The assessment of this phenotypic variation is of vital importance in the differential diagnosis of neurodegenerative diseases...
  68. ncbi Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
    H Houlden
    Neurogenetics, Clinical Neurology and Dementia Research Group, Institute of Neurology, London
    Neurology 56:1702-6. 2001
    ..05 > CI 95% > 1.85]). CONCLUSIONS: The CBD tau association described here suggests that PSP and CBD share a similar cause, although the pathogenic mechanism behind the two diseases leads to a different clinical and pathologic phenotype...
  69. ncbi Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation
    W S Brooks
    Prince of Wales Medical Research Institute, University of New South Wales, Barker Street, Randwick, Sydney, NSW 2031, Australia
    Neurology 63:1613-7. 2004
    ..The APPAla692Gly (Flemish) mutation was reported in a family in which affected members developed hemorrhagic stroke, progressive dementia, or both...